Deep Blue, Inc. produces and markets pharmaceuticals focusing on the treatment of viral infections. The company's products find applications in the treatment of Hepatitis C and HIV/AIDS. Additionally, it offers anti viral therapy research and development services. The company caters to private doctors, healthcare centers, and medical institutions. Deep Blue is headquartered in Montauk, New York.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for DPBL